Appointment of Scrutinizer for the 66th Annual General Meeting.

Negative operating cash flowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹81.50

prior close

₹80.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-7.2% vs market

Pharmaceuticals peers, median of 160sector+0.2%-6.3% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-3.5

15m

-4.3

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1+1.1-7.2+0.2-6.3

Next day

-6.2+1.2-7.4+0.2-6.4

-6.3+2.8-9.1+1.5-7.8

-6.1+3.5-9.7+1.4-7.6

-6.1+3.5-9.6+1.6-7.7

-6.1+2.8-9.0+1.0-7.2

-7.5+2.8-10.3+0.4-7.9

15d

-2.5+4.2-6.7+0.7-3.2

-3.2+10.1-13.3+3.1-6.3

-1.4+10.0-11.4+7.2-8.6

-6.3+14.6-20.8+8.2-14.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma Ltd reported FY2026 revenue of Rs. 77,165.74 Lakhs, up 16.6% from Rs. 66,151.49 Lakhs in FY2025. However, profit after tax declined 13.3% to Rs. 4,104.61 Lakhs from Rs. 4,735.19 Lakhs. EBITDA margin compressed significantly to 8.56% from 10.64% year-over-year. The company posted negative operating cash flow of Rs. 301.16 Lakhs versus positive Rs. 3,712.47 Lakhs in the prior year. The Board recommended a dividend of Rs. 1.50 per share (30% payout) subject to shareholder approval at the AGM on 12th August 2026. Statutory auditors issued an unmodified opinion on the audited financial results.

Likely market impact

The stock may face pressure due to PAT decline, margin compression, and negative operating cash flow despite revenue growth. The clean audit opinion is a positive factor. Dividend announcement provides some support for shareholders.

By the numbersStandalone · Q4 FY26 vs Q4 FY25

	Q4 FY26	Q4 FY25	Change
Revenue	₹202.1 Cr	₹198.1 Cr	+2.0%
Operating profit	₹16.77 Cr	₹15.88 Cr	+5.6%
Profit after tax	₹11.68 Cr	₹12.46 Cr	−6.2%
EBITDA margin	9.8%	9.4%	+0.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.